sofie_c557hm, Author at SOFIE - Page 8 of 12

About sofie_c557hm

This author has not yet filled in any details.
So far sofie_c557hm has created 112 blog entries.

FAPI Theragnostics
Gallery
FAPI Theragnostics

FAPI Theragnostics

sofie_c557hm2025-11-03T16:08:50+00:0031, Mar 2023|Presentations|

Presented by: Prof. Dr. Frederik L. Giesel, MD, MBA; Chair of Nuclear Medicine, Department of […]

Fibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology, Fibrotic Disease, and Cardiovascular Disease
Gallery
Fibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology, Fibrotic Disease, and Cardiovascular Disease

Fibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology, Fibrotic Disease, and Cardiovascular Disease

sofie_c557hm2025-11-04T00:28:35+00:0014, Mar 2023|Presentations|

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Informa Connect: Radiopharmaceuticals and Imaging Digital Conference
March […]

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease
Gallery
FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease

sofie_c557hm2025-10-13T13:38:53+00:005, Feb 2023|Publications|

Yuriko Mori¹, Katharina Dendl¹, Jens […]

Novel 68Ga-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls
Gallery
Novel 68Ga-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls

Novel 68Ga-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls

sofie_c557hm2025-10-15T16:40:44+00:005, Feb 2023|Publications|

Tristan T Demmert¹, Ines Maric¹,

IND granted for FAP targeting therapeutic in SOFIE partnership
Gallery
IND granted for FAP targeting therapeutic in SOFIE partnership

IND granted for FAP targeting therapeutic in SOFIE partnership

sofie_c557hm2025-10-15T16:42:14+00:0017, Jan 2023|News|

Dulles, VA – January 17, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]

SOFIE granted IND for 18F-FAPI in Phase 2 study
Gallery
SOFIE granted IND for 18F-FAPI in Phase 2 study

SOFIE granted IND for 18F-FAPI in Phase 2 study

sofie_c557hm2025-10-15T16:42:14+00:0029, Nov 2022|News|

Dulles, VA – November 29, 2022 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]

Initial Results of FAPI-PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
Gallery
Initial Results of FAPI-PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer

Initial Results of FAPI-PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer

sofie_c557hm2025-10-13T13:39:20+00:0017, Nov 2022|Publications|

Philipp Backhaus¹, Matthias C Burg²,

3-time-point PET-analysis of FAPI-46 in a variety of cancers
Gallery
3-time-point PET-analysis of FAPI-46 in a variety of cancers

3-time-point PET-analysis of FAPI-46 in a variety of cancers

sofie_c557hm2025-10-13T13:39:26+00:0010, Nov 2022|Publications|

Mahnoosh Naeimi¹, Peter L Choyke²,

FAPI Clinical Development Updates
Gallery
FAPI Clinical Development Updates

FAPI Clinical Development Updates

sofie_c557hm2025-11-03T16:09:10+00:005, Nov 2022|Presentations|

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
ICPO Theranostics FAP Summit (virtual)
November 5, 2022 […]

Previous 789 Next